Stay updated on Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.

Latest updates to the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated to reflect a new version (v2.15.0) and a future date (2025-04-10), replacing the previous version (v2.14.4) and an earlier date (2025-01-08).SummaryDifference2%
- Check16 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 8, 2025, while a date for March 25, 2025, has been removed.SummaryDifference1.0%
- Check23 days agoNo Change Detected
- Check59 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check73 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check80 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
Stay in the know with updates to Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.